Shandong Boan Biotechnology Co Ltd
HKEX:6955
Wall Street
Price Targets
Price Targets Summary
Shandong Boan Biotechnology Co Ltd
According to Wall Street analysts, the average 1-year price target for Shandong Boan Biotechnology Co Ltd is 10.4 HKD with a low forecast of 10.3 HKD and a high forecast of 10.71 HKD.
Revenue
Forecast
Revenue Estimate
Shandong Boan Biotechnology Co Ltd
For the last 3 years the compound annual growth rate for Shandong Boan Biotechnology Co Ltd's revenue is 66%. The projected CAGR for the next 2 years is 33%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Shandong Boan Biotechnology Co Ltd's stock price target?
Price Target
10.4
HKD
According to Wall Street analysts, the average 1-year price target for Shandong Boan Biotechnology Co Ltd is 10.4 HKD with a low forecast of 10.3 HKD and a high forecast of 10.71 HKD.
What is Shandong Boan Biotechnology Co Ltd's Revenue forecast?
Projected CAGR
33%
For the last 3 years the compound annual growth rate for Shandong Boan Biotechnology Co Ltd's revenue is 66%. The projected CAGR for the next 2 years is 33%.
What is Shandong Boan Biotechnology Co Ltd's Operating Income forecast?
Projected CAGR
35%
The compound annual growth rate of Shandong Boan Biotechnology Co Ltd's operating income for the next 2 years is 35%.
What is Shandong Boan Biotechnology Co Ltd's Net Income forecast?
Projected CAGR
63%
The compound annual growth rate of Shandong Boan Biotechnology Co Ltd's net income for the next 2 years is 63%.